Needham & Company on Endo Pharmaceuticals (ENDP): Watson (WPI) Gains First Generic Lidoderm Approval; A Few Other Issues Too

Go back to Needham & Company on Endo Pharmaceuticals (ENDP): Watson (WPI) Gains First Generic Lidoderm Approval; A Few Other Issues Too
ENDO INTERNAT (NASDAQ: ENDP) Delayed: 0.29 --0 (-0%)
Previous Close $0.29    52 Week High $63.71 
Open $0.02    52 Week Low $12.56 
Day High $0.29    P/E N/A 
Day Low $0.29    EPS $0.00 
Volume 24,300       

IMPAX LABORATORIES, Inc. (NASDAQ: IPXL) Delayed: 18.30 --0 (-0%)
Previous Close $18.30    52 Week High $45.00 
Open $0.04    52 Week Low $13.35 
Day High $18.30    P/E 12.45 
Day Low $18.30    EPS $1.47 
Volume 10,600       

Mylan Inc. (NASDAQ: MYL) Delayed: 15.86 --0 (-0%)
Previous Close $15.86    52 Week High $55.51 
Open $10.56    52 Week Low $33.60 
Day High $15.86    P/E 10.43 
Day Low $15.86    EPS $1.52 
Volume 45,581       

Par Pharmaceutical Cos., Inc. (NYSE: PRX) Delayed: 49.98 --0 (-0%)
Previous Close $49.98    52 Week High $52.33 
Open $0.02    52 Week Low $26.57 
Day High $49.98    P/E 24.26 
Day Low $49.98    EPS $2.06 
Volume 7,000       

Watson Pharmaceuticals, Inc. (NYSE: WPI) Delayed: 85.73 --0 (-0%)
Previous Close $85.73    52 Week High $91.47 
Open $16.30    52 Week Low $57.16 
Day High $85.73    P/E 66.46 
Day Low $85.73    EPS $1.29 
Volume 3,625